| Serial Number | 98377551 |
| Word Mark | TAKEDA |
| Filing Date | Friday, January 26, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 17, 2024 |
| Registration Number | 7608206 |
| Registration Date | Tuesday, December 17, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 15, 2024 |
| Description of Mark | The mark consists of the word "TAKEDA" in stylized lettering, appearing inside of two intersecting arcs, the lower arc with a straight line on the bottom and the higher arc being thicker in size and with two sides extending over the lower arc. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Wednesday, January 1, 2020 |
| First Use In Commerce Date | Wednesday, January 1, 2020 |
| Party Name | Takeda Pharmaceutical Company Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 541-0045 JP |
| Party Name | Takeda Pharmaceutical Company Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 541-0045 JP |
| Party Name | Takeda Pharmaceutical Company Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Osaka 541-0045 JP |
| Event Date | Event Description |
| Friday, January 26, 2024 | NEW APPLICATION ENTERED |
| Wednesday, July 31, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, July 31, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 21, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, August 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 21, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 21, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 15, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 15, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 17, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 17, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |